Generic drug of Cerazette
Therapeutic class: Contraception and termination of pregnancy
active ingredients: Desogestrel
laboratory: Sanofi-Aventis France
Box of 1 Plate of 28
Dosage DESOGESTREL ZENTIVA 75 μg 0.075 mg Film-coated tablet Box of 1 Pack of 28
There are no data available on the safety and effectiveness of desogestrel in adolescents under 18 years of age.
No previous hormonal contraception (during the last cycle):
One tablet a day every day without interruption at the same time, so the interval between taking 2 tablets is always 24 hours.
The first tablet should be taken on the first day of menstruation. Treatment can also be started between day 2 and day 5 if you use a mechanical contraceptive method (eg condom) for the first seven days of taking this medication.
The first tablet of the following wafer must be taken the day after the day the previous wafer was completed.
Relay of combined hormonal contraceptive (combined oral contraceptive (COC), vaginal ring or transdermal patch):
The woman should start this medication the day after taking the last active tablet (the last tablet containing the active ingredients) from her previous COC. If a vaginal ring or transdermal patch is relayed, this medication should be started on the day of withdrawal. In these cases, the use of additional contraception is not necessary.
Relay of a progestogen-only method (microprogestative pill, injection, implant or intrauterine device releasing a progestin):
In relay of a microprogestative pill, the woman will be able to relay any day. In relay of the implant or of an intrauterine device releasing a progestin, the day of their withdrawal; Relay of a progestin-only injectable, the day scheduled for the next injection.
After a birth or after a second trimester abortion:
For breastfeeding women, see section Pregnancy and breastfeeding .
The woman will be advised to start between the 21st and the 28th day after second trimester delivery or abortion. If you start taking it later, you will be advised to use a mechanical contraceptive method for the first 7 days. However, if sexual intercourse has already occurred, a pregnancy should be excluded before starting this medication otherwise the woman will have to wait for her first period while using a mechanical contraceptive method (eg condom).
After a first trimester abortion:
It is recommended to start treatment immediately. In this case, it is not necessary to use additional contraceptive method.
Advice if you forget a tablet:
Contraceptive protection may be reduced if more than 36 hours elapse between 2 tablets.
If you forget to take 12 hours after the usual time, take the missed tablet immediately and take the next tablet at the usual time.
If the forgetfulness is observed more than 12 hours after the normal time of the catch, the woman will have to take the last forgotten tablet as soon as she notes the oblivion and to take the next tablet at the usual time, even if that leads taking 2 tablets at the same time. In addition, a mechanical contraceptive method (eg condom) should be used for at least 7 days.
If this forgetfulness of more than 12 hours has occurred during the first week of use and sexual intercourse has occurred during the 7 days preceding this forgetfulness, there is a risk of pregnancy.
Advice in case of gastrointestinal disorders:
If vomiting occurs within 3-4 hours after taking a tablet, similarly in case of severe diarrhea, absorption may not be complete and these cases should be considered as no intake. For further information, refer to the tips in the "Advice on forgetting a tablet" section.
In the case where a new tablet is needed, if the woman does not want to change her normal tablet schedule, she can take the extra tablet (s) in another one. wafer.
· Hypersensitivity to the active substance or to any of the excipients.
· Evolutionary venous thromboembolic accidents.
· Presence or history of severe liver disease, as long as hepatic function parameters are not normalized.
· Progestin-sensitive tumors (eg, breast cancer).
· Unexplained genital hemorrhage.
· In combination with St. John's Wort (see section Interactions with other medicinal products and other forms of interaction ).
Side effects Desogestrel Zentiva 75 μG
System Organ Class (MedDRA) version 6.0.
Frequency of adverse reactions
Frequent ≥ 1/1 0 0
Not very frequent <1/100, ≥1 / 1000
Infections and infestations
Mood modification, decreased libido
Nervous system disorders
Contact lens intolerance
Skin and subcutaneous tissue disorders
Rash, hives, erythema nodosum
Disorders of the genital tract and breasts
Mastodynia, irregular bleeding, amenorrhea
Dysmenorrhea, ovarian cyst
General disorders and condition related to the site of administration